Einstein Aging Study
The Einstein Aging Study (EAS), first funded by the NIA in 1993, has, since its inception, focused on remediable risk factors and biological pathways that lead to cognitive decline, dementing disorders, and the intermediate states that precede them.
Its goals are:
Overview
- Acronym
- EAS
- Investigators
-
- Contacts
-
General Design
- Study design
- Cohort
- Start - End Year
- 1993 -
- General Information on Follow Up (profile, frequency)
-
After baseline, participants are followed yearly.
- Recruitment Target
-
- Individuals
- Number of Participants
- 2,600
- Number of Participants with Biological Samples
- 2,600
Access
Availability of data and biosamples
Possible Access to Data | |
Possible Access to Biosamples | |
Other |
|
Marker Papers
Katz, M.J. et al. Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord, 2012 Oct-Dec;26(4):335-43.
PUBMED 22156756Timeline
Population
The population is composed of men and women who are at least 70 years of age, Bronx residents, non-institutionalized, and English speaking.
Selection Criteria
- Minimum age
-
70
- Countries
-
- United States of America
- Territory
-
Bronx County, NY
- Health Status
-
Exclusion criteria included visual or auditory impairments that preclude neuropsychological testing, active psychiatric symptomatology that interfered with the ability to complete assessments, and non-ambulatory status.
- Other Criteria
-
Eligible participants were non-institutionalized and English speaking. p>
Sources of Recruitment
- General Population
-
- Selected sample
Sample Size
- Number of Participants
- 2,600
- Number of Participants with Biological Samples
- 2,600
Data Collection Events
# | Name | Data sources | Data sources - Biosamples | Start | End |
---|---|---|---|---|---|
0 | EAS - Baseline |
|
|
1993 | 1994 |
1 | EAS - Follow-up 1 |
|
|
1994 | 1995 |
2 | EAS - Follow-up 2 |
|
|
1995 | 1996 |
3 | EAS - Follow-up 3 |
|
|
1996 | 1997 |
4 | EAS - Follow-up 4 |
|
|
1997 | 1998 |
5 | EAS - Follow-up 5 |
|
|
1998 | 1999 |
6 | EAS - Follow-up 6 |
|
|
1999 | 2000 |
7 | EAS - Follow-up 7 |
|
|
2000 | 2001 |
8 | EAS - Follow-up 8 |
|
|
2001 | 2002 |
9 | EAS - Follow-up 9 |
|
|
2002 | 2003 |
10 | EAS - Follow-up 10 |
|
|
2003 | 2004 |
11 | EAS - Follow-up 11 |
|
|
2004 | 2005 |
12 | EAS - Follow-up 12 |
|
|
2005 | 2006 |
13 | EAS - Follow-up 13 |
|
|
2006 | 2007 |
14 | EAS - Follow-up 14 |
|
|
2007 | 2008 |
15 | EAS - Follow-up 15 |
|
|
2008 | 2009 |
16 | EAS - Follow-up 16 |
|
|
2009 | 2010 |
17 | EAS - Follow-up 17 |
|
|
2010 | 2011 |
18 | EAS - Follow-up 18 |
|
|
2011 | 2012 |
19 | EAS - Follow-up 19 |
|
|
2012 | 2013 |
20 | EAS - Follow-up 20 |
|
|
2013 | 2014 |
21 | EAS - Follow-up 21 |
|
|
2014 | 2015 |
22 | EAS - Follow-up 22 |
|
|
2015 | 2016 |
23 | EAS - Follow-up 23 |
|
|
2016 | 2017 |
24 | EAS - Follow-up 24 |
|
|
2017 | 2018 |
Participating Studies
Acronym | Name | Study design | Countries |
---|
Harmonization Initiatives Included
Acronym | Name |
---|
Datasets
Name | Data Collection Events | Variables |
---|
Areas of Information Collected
- Socio-demographic and economic characteristics
- Death
- Lifestyle and behaviours
- Physical measures and assessments
- Birth, pregnancy and reproductive health history
- Laboratory measures
- Perception of health, quality of life, development and functional limitations
- Cognition, personality and psychological measures and assessments
- Diseases
- Life events, life plans, beliefs and values
- Symptoms and signs
- Preschool, school and work life
- Medication and supplements
- Social environment and relationships
- Non-pharmacological interventions
- Physical environment
- Health and community care services utilization
- Administrative information
Variables Content Summary
Areas of Information Collected
Areas of Information Collected per per Population and Data Collection Event
Networks
Acronym | Name | Harmonization Initiatives | Individual Studies |
---|